Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
6.77
-0.36 (-5.05%)
At close: Jan 29, 2026, 4:00 PM EST
6.77
0.00 (0.00%)
After-hours: Jan 29, 2026, 4:00 PM EST
Cybin Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
337.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 686.88K | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Enanta Pharmaceuticals | 65.32M |
| Autolus Therapeutics | 51.13M |
| Foghorn Therapeutics | 24.52M |
| Aclaris Therapeutics | 15.74M |
| Lineage Cell Therapeutics | 10.82M |
| AC Immune | 5.48M |
HELP News
- 4 weeks ago - Cybin Initiates At-The-Market Equity Program of up to US$100 Million - Business Wire
- 6 weeks ago - Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq - Business Wire
- 2 months ago - Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights - Business Wire
- 2 months ago - Cybin to Participate in the Jefferies Global Healthcare Conference in London - Business Wire
- 3 months ago - Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025 - Business Wire
- 3 months ago - Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - Business Wire
- 3 months ago - Cybin to Participate at the 2025 Milken Institute Future of Health Summit - Business Wire